+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      The Further Metabolism of Sorbitol-3-Phosphate and Fructose-3-Phosphate in the Mature Rat Lens

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Glucose and phosphorus metabolism in mature (8-month-old) rat lenses were examined with NMR spectroscopy. Nondia-betic mature lenses contained sorbitol-3-phosphate (S3P) and fructose-3-phosphate (F3P) which were absent from young (1-to 2-month-old) normal rat lenses. The concentrations of these two phosphates can be changed through (1) diabetes induction with streptozotocin – this results in a dramatic increase in both compounds; and (2) oral dosing with a drug known to prevent sorbitol production – both metabolites disappeared. When normal mature lenses were incubated in 35.5 m M<sup>13</sup>C<sub>1</sub>-glucose, both <sup>13</sup>C<sub>1</sub>-lactate and <sup>13</sup>C<sub>3</sub>-lactate were produced. Preservation of the <sup>13</sup>C label at Q is likely through the formation of <sup>13</sup>C<sub>1</sub>-S3P and -F3P, which were then split through an aldolase-like mechanism into two 3-carbon compounds, one an unlabeled glycerol and the other <sup>13</sup>C<sub>1</sub>-α-glycerophosphate (from S3P) and <sup>13</sup>C<sub>1</sub>-dihydroxyacetone phosphate (from F3P). These reactions can contribute to the increase in α-glycero phosphate observed in both the streptozotocin-induced diabetic lenses and lenses incubated in high glucose.

          Related collections

          Author and article information

          Ophthalmic Res
          Ophthalmic Research
          S. Karger AG
          11 December 2009
          : 28
          : 1
          : 57-63
          NMR Research, Howe Laboratory of Ophthalmology, Harvard Medical School, and Massachusetts Eye and Ear Infirmary, Boston, Mass., USA
          267874 Ophthalmic Res 1996;28:57–63
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Original Paper


          Comment on this article